VEGFA and glioblastoma: Based on the current achievements, we propose to perform prospective clinical trials in which we obtain VEGFA expression levels using ddPCR to detect and quantify ctDNA levels in GBM patient blood and cerebrospinal fluid to confirm the close correlation between VEGFA expression and peripheral blood tests.